Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School

Last Updated: December 5, 2021

DrugPatentWatch Database Preview

Details for Patent: 8,664,187

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,664,187 protect, and when does it expire?

Patent 8,664,187 protects TOBI PODHALER and is included in one NDA.

This patent has thirty patent family members in twenty-five countries.

Summary for Patent: 8,664,187
Title:Methods of treatment of endobronchial infections
Abstract: The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition comprising from 90 to 130 mg of an aminoglycoside antibiotic one to three times a day for a first treatment period of 20 to 36 days.
Inventor(s): Challoner; Peter (Emeryville, CA), Rodriguez; Carlos (Emeryville, CA), Samara; Emil (Emeryville, CA), Tarara; Thomas E (Burlingame, CA), Lord; John D (San Carlos, CA)
Assignee: Novartis AG (Basel, CH)
Application Number:13/404,359
Patent Claim Types:
see list of patent claims
Use; Formulation; Process;

Drugs Protected by US Patent 8,664,187

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mylan Speciality Lp TOBI PODHALER tobramycin POWDER;INHALATION 201688-001 Mar 22, 2013 RX Yes Yes ⤷  Try it Free ⤷  Try it Free TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.